Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Crespo

Showing results (431-440 of 509) with videos related to

Pageof 51
Sort By:
Transplantation Proceedings|October 26, 2010
The prognosis of noncutaneous, nonlymphomatous malignancy after heart transplantation: data from the Spanish Post-Heart Transplant Tumour RegistryM G Crespo-Leiro, L A Alonso-Pulpón, A Villa-Arranz, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 6, 2017
Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access ProgramM González-Cao, A Arance, J M Piulats, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 23, 2013
Primary graft failure after heart transplantation: characteristics in a contemporary cohort and performance of the RADIAL risk scoreM Dolores G Cosío Carmena, Manuel Gómez Bueno, Luis Almenar, et al.
JACC. Heart Failure|June 2, 2026
Ambulatory Stage C2D Heart Failure Definitions and Current Therapeutic Approaches: JACC: Heart Failure Position StatementShannon M Dunlay, Monica Colvin, Jennifer A Cowger, et al.
Circulation|November 22, 2021
Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan RemodelingJavier Barallobre-Barreiro, Tamás Radovits, Marika Fava, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2010
Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)R Garcia-Carbonero, J Capdevila, G Crespo-Herrero, et al.
Transplantation|June 16, 2026
Clinical Phenotypes in Heart Transplantation: Implications for Prognosis and Personalized Follow-upPedro Caravaca-Pérez, Luis Almenar-Bonet, María G Crespo-Leiro, et al.
European Journal of Heart Failure|May 29, 2018
Advanced heart failure: a position statement of the Heart Failure Association of the European Society of CardiologyMaria G Crespo-Leiro, Marco Metra, Lars H Lund, et al.
Revista Espanola De Cardiologia (English Ed.)|March 25, 2020
Validation of the usefulness of 2-dimensional strain parameters to exclude acute rejection after heart transplantation: a multicenter studyJosebe Goirigolzarri Artaza, Susana Mingo Santos, José María Larrañaga, et al.
Clinical Transplantation|August 8, 2014
The falling incidence of hematologic cancer after heart transplantationM G Crespo-Leiro, J Delgado-Jiménez, L López, et al.
Pageof 51

Showing results (431-440 of 509) with videos related to

Sort By:
Pageof 51
Transplantation Proceedings|October 26, 2010
The prognosis of noncutaneous, nonlymphomatous malignancy after heart transplantation: data from the Spanish Post-Heart Transplant Tumour RegistryM G Crespo-Leiro, L A Alonso-Pulpón, A Villa-Arranz, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 6, 2017
Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access ProgramM González-Cao, A Arance, J M Piulats, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 23, 2013
Primary graft failure after heart transplantation: characteristics in a contemporary cohort and performance of the RADIAL risk scoreM Dolores G Cosío Carmena, Manuel Gómez Bueno, Luis Almenar, et al.
JACC. Heart Failure|June 2, 2026
Ambulatory Stage C2D Heart Failure Definitions and Current Therapeutic Approaches: JACC: Heart Failure Position StatementShannon M Dunlay, Monica Colvin, Jennifer A Cowger, et al.
Circulation|November 22, 2021
Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan RemodelingJavier Barallobre-Barreiro, Tamás Radovits, Marika Fava, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2010
Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)R Garcia-Carbonero, J Capdevila, G Crespo-Herrero, et al.
Transplantation|June 16, 2026
Clinical Phenotypes in Heart Transplantation: Implications for Prognosis and Personalized Follow-upPedro Caravaca-Pérez, Luis Almenar-Bonet, María G Crespo-Leiro, et al.
European Journal of Heart Failure|May 29, 2018
Advanced heart failure: a position statement of the Heart Failure Association of the European Society of CardiologyMaria G Crespo-Leiro, Marco Metra, Lars H Lund, et al.
Revista Espanola De Cardiologia (English Ed.)|March 25, 2020
Validation of the usefulness of 2-dimensional strain parameters to exclude acute rejection after heart transplantation: a multicenter studyJosebe Goirigolzarri Artaza, Susana Mingo Santos, José María Larrañaga, et al.
Clinical Transplantation|August 8, 2014
The falling incidence of hematologic cancer after heart transplantationM G Crespo-Leiro, J Delgado-Jiménez, L López, et al.
Pageof 51